Clinical Trial Update: MR-Adaptive Radiation Therapy for Anal Cancer With EScalated-Treatment in a Risk-Optimized Approach [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating MR-Adaptive Radiation Therapy with escalated treatment in a risk-optimized approach for anal squamous cell carcinoma is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Squamous Cell Carcinoma

Snippet

Sponsor: University Health Network, Toronto | Conditions: Anal Squamous Cell Carcinoma | Phase 2 | Status: RECRUITING